At NEBULA, we revolutionize drug discovery by providing a comprehensive, physics-based dataset-free genAI solution for mapping the full range of therapeutic target conformations. Unlike traditional drug development focused on small molecule screening, our innovative approach delves deep into the dynamic nature of macromolecular targets—proteins, mRNA, antigens—unveiling their multitude of physiological conformations.
Our dataset-free technology integrates generative genAI with molecular dynamics, rooted in physical principles, to generate an exhaustive profile of potential target structures without relying on pre-existing data. By enhancing the understanding of drug targets, we empower pharmaceutical and biotech companies to identify more effective therapeutic molecules, reducing the high failure rates associated with current computational predictions.
As a partnership-focused company, NEBULA collaborates closely with pharma and biotech firms, offering customized services.
Join us in transforming the drug discovery landscape by unlocking the full potential of therapeutic targets through cutting-edge dataset-free genAI
Company Details
- Employees
- 4
- Founded
- -
- Address
- Nancy, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://nebulabio.tech/
- HQ
- Nancy
Nebula Questions
Nebula's website is https://nebulabio.tech/
Nebula's LinkedIn profile is https://fr.linkedin.com/company/nebulabiotech
Nebula has
4 employees.
View email and phone details for 4
employees at Nebula.
Nebula's industry is
Biotechnology Research
Nebula's top competitors are
Aprex Solutions,
Novelit,
Reviviscens,
Iglobe Scientific,
Scialytics,
Fixout,
Catsalyze,
Noviga,
Cyber4care | Archify.fr,
Weeemet.
Nebula's categories are Biotechnology Research
Nebula's founding year is 2024
